acrylamide has been researched along with Escherichia coli Infections in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Higashi, N; Igai, K; Kita, E; Matsuoka, K; Miyagawa, A; Natori, Y; Nishikawa, K; Samejima, Y; Terunuma, D; Watanabe, M; Watanabe, T; Yanoshita, R | 1 |
1 other study(ies) available for acrylamide and Escherichia coli Infections
| Article | Year |
|---|---|
Oral therapeutic agents with highly clustered globotriose for treatment of Shiga toxigenic Escherichia coli infections.
Topics: Acrylamide; Animals; Brain Chemistry; Carbohydrate Sequence; Disease Models, Animal; Dose-Response Relationship, Drug; Escherichia coli Infections; Escherichia coli O157; Female; Hemolytic-Uremic Syndrome; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Polymers; Protein Binding; Receptors, Cell Surface; Shiga Toxin 1; Shiga Toxin 2; Shiga Toxins; Trihexosylceramides; Trisaccharides | 2004 |